Full Length Research Paper
References
|
Al-Baqsami ZF, Ahmad S, Khan Z (2020). Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Scientific Reports 10(1):6238. |
|
|
Anderson MR, Klink K, Cohrssen A (2004). Evaluation of vaginal complaints. Journal of the American Medical Association 291(11):1368-1379. |
|
|
Angora KE, Djohan V, Ira-Bonouman VA, Vanga-Bosson HA, Kassi KF, Konate A, Bedia-Tanoh VA, Miezan SA, Kiki-Barro CP, Menan H, Touré AO, Yavo W (2018). Susceptibility of Candida species isolated from recurrent vulvovaginal candidiasis to antifungal agents among women at Institut Pasteur of Côte d'Ivoire. Journal of Yeast and Fungal Research 9(3):21-26. |
|
|
Berkow EL, Lockhart SR, Ostrosky-Zeichner L (2020). Antifungal susceptibility testing: current approaches. Clinical Microbiology Reviews 33(3):e00069-19. |
|
|
Bilal H, Shafiq M, Hou B, Islam R, Khan MN, Khan RU, Zeng Y (2022). Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis. Virulence 13(1):1573-1589. |
|
|
Chassot F, Negri MFN, Svidzinski AE, Donatti L, Peralta RM, Svidzinski TIE, Consolaro MEL (2008). Can intrauterine contraceptive devices be a Candida albicans reservoir? Contraception 77(5):355-359. |
|
|
Djohan V, Angora KE, Vanga-Bosson AH, Konaté A, Kassi FK, Yavo W, Kiki-Barro PC, Menan H, Koné M (2012). Sensibilité in vitro des souches de Candida albicans d'origine vaginale aux antifongiques à Abidjan (Côte d'Ivoire). Journal de Mycologie Médicale 22(2):129-133. |
|
|
Djohan V, Angora KE, Vanga-Bosson AH, Konaté A, Kassi KF, Kiki-Barro PCM, Bedia-Tanoh AV, Miezan S, Menan EIH, Yavo W (2019). Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d'Ivoire): Aetiology and associated factors. Journal de Mycologie Médicale 29(2):127-131. |
|
|
Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ (2018). Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360(6390):739-742. |
|
|
Foxman B, Muraglia R, Dietz J-P, Sobel JD, Wagner J (2013). Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. Journal of Lower Genital Tract Disease 17(3):340-345. |
|
|
Góralska K, Szybka M, Karuga FF, Pastuszak-Lewandoska D, Brzezia?ska-Lasota E (2024). Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate. Journal of Medical Mycology 34(2):101476. |
|
|
Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E (2006). Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. European Journal of Obstetrics and Gynecology and Reproductive Biology 126(1):121-125. |
|
|
Jeanmonod R, Chippa V, Jeanmonod D (2023). Vaginal candidiasis. In: StatPearls StatPearls Publishing, Treasure Island (FL). |
|
|
Konaté A, Yavo W, Kassi FK, Djohan V, Angora EK, Barro-Kiki PC, Bosson-Vanga H, Soro F, Menan EIH (2014). Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire). Journal de Mycologie Médicale 24(2):93-99. |
|
|
Lírio J, Giraldo PC, Amaral RL, Sarmento ACA, Costa APF, Gonçalves AK (2019). Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. BMJ Open 9(5):e027489. |
|
|
Makanjuola O, Bongomin F, Fayemiwo SA (2018). An Update on the roles of non-albicans Candida species in vulvovaginitis. Journal of Fungi (Basel) 4(4):121. |
|
|
Nyirjesy P, Sobel JD (2003). Vulvovaginal candidiasis. Obstetrics and Gynecology Clinics of North America 30(4):671-684. |
|
|
Oxman DA, Chow JK, Frendl G, Hadley S, Hershkovitz S, Ireland P, McDermott LA, Tsai K, Marty FM, Kontoyiannis DP, Golan Y (2010). Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? Journal of Antimicrobial Chemotherapy 65(7):1460-1465. |
|
|
Pfaller MA, Jones RN, Castanheira M (2014). Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011. Mycoses 57(10):602-611. |
|
|
Phillips NA, Bachmann G, Haefner H, Martens M, Stockdale C (2022). Topical treatment of recurrent vulvovaginal candidiasis: An expert consensus. Women's Reproductive Health (New Rochelle) 3(1):38-42. |
|
|
Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD (2017). Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Frontiers in Microbiology 7:2173. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
